This mind Map was created By Jana Shaker and it was revised and edited By Dr Arwa M Amin. The information of the mind-map are from:
Chapter 96: Menstruation-Related Disorders, Pharmacotherapy: A Pathophysiologic Approach, 11e
For more notes: Join Us on Telegram: https://t.me/OBGYN_Note_Book Or Facebook: https://www.facebook.com/obgyn.books
Slideshare: https://www.slideshare.net/bjlomsecond
The increased cardiac output related to pregnancy can lead to heart failure, and the increased heart rate in the third trimester can lead to ischemic events. The potential obstetrical complications include preeclampsia or other hypertensive related disorders, premature birth, and small-for-gestational-age births
For more notes: Join Us on Telegram: https://t.me/OBGYN_Note_Book Or Facebook: https://www.facebook.com/obgyn.books
Slideshare: https://www.slideshare.net/bjlomsecond
The increased cardiac output related to pregnancy can lead to heart failure, and the increased heart rate in the third trimester can lead to ischemic events. The potential obstetrical complications include preeclampsia or other hypertensive related disorders, premature birth, and small-for-gestational-age births
This Mind Map was created By Lina Al Harbi and it was revised and edited By Dr Arwa M Amin. The information of the mind-map are from:
Chapter 96: Menstruation-Related Disorders, Pharmacotherapy: A Pathophysiologic Approach, 11e
LAW: THE SUM TOTAL OF RULES AND REGULATIONS BY WHICH THE SOCIETY IS GOVERNED
ETHICS: Ethics is the systematic study of What a persons conduct ought to be with regard to him or herself, other human beings and the environment, it is the justification of what is right or good and the study of what a person’s life and relationship ought to be, not necessarily what they are.
Learn about application of various types of fetal monitoring during antenatal visit, complicated pregnancy and during labour such as continous, intermittent, ambulatory, hands on auscultation and internal monitoring.
Finalmente saiu a atualização do manual da OMS sobre PARTO e NASCIMENTO. A 1a. edição foi publicada há mais de 20 anos atrás - 1996!
Desde então, tivemos no ano passado a publicação das diretrizes do Ministério da Saúde, para cesárea e parto normal, um trabalho colaborativo de grande porte, denso, em que muit@s de nós tivemos o privilégio de poder contribuir.
E esta semana saiu! Ainda está apenas em inglês, espero que em breve esteja acessível em outros idiomas. Incluindo o nosso!
Algumas coisas do que dá para perceber lendo o sumário a partir da página 3:
- o foco principal é na redução de intervenções sem indicação precisa
- inova ao incluir como resultado a mulher relatar o parto como uma experiência positiva
- adorei a proposta de um toque vaginal a cada 4h no primeiro estágio, fase latente
- recomenda banho do bebê só depois de 24 horas (afora contato pele-a-pele, amamentação na primeira hora etc)
- inclui cuidados com a mulher no pós-parto imediato
- esta versão integra recomendações provenientes de outros documentos da OMS
Bem - agora é ler, tomar conhecimento e adotar como referência, né?
Muito, muito bom!
Dizem que o ano começa, de verdade, após o carnaval - taí! começou bem!
Cordialmente,
Daphne Rattner
ReHuNa
This Mind Map was created By Lina Al Harbi and it was revised and edited By Dr Arwa M Amin. The information of the mind-map are from:
Chapter 96: Menstruation-Related Disorders, Pharmacotherapy: A Pathophysiologic Approach, 11e
LAW: THE SUM TOTAL OF RULES AND REGULATIONS BY WHICH THE SOCIETY IS GOVERNED
ETHICS: Ethics is the systematic study of What a persons conduct ought to be with regard to him or herself, other human beings and the environment, it is the justification of what is right or good and the study of what a person’s life and relationship ought to be, not necessarily what they are.
Learn about application of various types of fetal monitoring during antenatal visit, complicated pregnancy and during labour such as continous, intermittent, ambulatory, hands on auscultation and internal monitoring.
Finalmente saiu a atualização do manual da OMS sobre PARTO e NASCIMENTO. A 1a. edição foi publicada há mais de 20 anos atrás - 1996!
Desde então, tivemos no ano passado a publicação das diretrizes do Ministério da Saúde, para cesárea e parto normal, um trabalho colaborativo de grande porte, denso, em que muit@s de nós tivemos o privilégio de poder contribuir.
E esta semana saiu! Ainda está apenas em inglês, espero que em breve esteja acessível em outros idiomas. Incluindo o nosso!
Algumas coisas do que dá para perceber lendo o sumário a partir da página 3:
- o foco principal é na redução de intervenções sem indicação precisa
- inova ao incluir como resultado a mulher relatar o parto como uma experiência positiva
- adorei a proposta de um toque vaginal a cada 4h no primeiro estágio, fase latente
- recomenda banho do bebê só depois de 24 horas (afora contato pele-a-pele, amamentação na primeira hora etc)
- inclui cuidados com a mulher no pós-parto imediato
- esta versão integra recomendações provenientes de outros documentos da OMS
Bem - agora é ler, tomar conhecimento e adotar como referência, né?
Muito, muito bom!
Dizem que o ano começa, de verdade, após o carnaval - taí! começou bem!
Cordialmente,
Daphne Rattner
ReHuNa
A 38 slide power-point presentation for medical students years 4 or 5. The idea to familiarize with classification, clinical features, diagnosis and management.
Abnormal uterine bleeding (AUB) is bleeding from the uterus that is longer than usual or that occurs at an irregular time. Bleeding may be heavier or lighter than usual and occur often or randomly. AUB can occur: As spotting or bleeding between your periods.
(ضبط أدوية السكر على النظام الغذائي منخفض الكربوهيدرات (نظام اللوكاربArwa M. Amin
ويبنار التغذية العلاجية بنظام اللوكارب لمرضى السكري النوع الثاني و ضبط أدوية السكري على النظام
لمشاهدة المحاضرة كاملة
https://youtu.be/-6ri8WvlpNY
هذه المحاضرة تهدف إلى تقديم الوعي و التثقيف الصحي و لا تقدم أي استشارة طبية
و على المريض استشارة طبيبه المعالج لتعديل الخطة الدوائية قبل اتباع النظام
Pharmacotherapy of Ischemic Heart Disease (IHD)Arwa M. Amin
This Presentation is for educational purposes and it has no profit associated with it.
References for this Presentation:
Pharmacotherapy: A Pathophysiologic Approach, 11e
This Presentation is for educational purposes and it has no profit associated with it.
References for this Presentation:
Pharmacotherapy: A Pathophysiologic Approach, 11e
Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D et al. 2020 International Society of Hypertension Global Hypertension Practice Guidelines. 2020;75(6):1334-57. doi:doi:10.1161/HYPERTENSIONAHA.120.15026.
Foo LF, Tay J, Wilkinson I. Treatment Options for Hypertension in Pregnancy. In: Lees C, Gyselaers W, editors. Maternal Hemodynamics. Cambridge: Cambridge University Press; 2018. p. 141-60.
F. Sacchet-Cardozo, MD et al, 2016 Revisiting Clevidipine Experience in the Pediatric Population: a Perioperative Perspective
التغذية العلاجية بنظام غذائي منخفض الكربوهيدرات لمرض السكر من النوع الثانيArwa M. Amin
عرض التغذية العلاجية بنظام غذائي منخفض الكربوهيدرات لمرض السكر من النوع الثاني في ويبنار حياة صحية خالية من المضاعفات لمرض السكري
لمشاهدة المحاضرة على يوتيوب:
https://www.youtube.com/watch?v=cSBvUnKA6b4&t=5s
لتحميل جداول معالق السكر بعدة لغات
https://phcuk.org/sugar/
لورقة علمية تشرح الجزء المتعلق بالحلقة المفرغة لمقاومة الانسولين و ارتفاع الانسولين
https://onlinelibrary.wiley.com/doi/f...
LCHF Diet as an Effective Therapy for T2DMArwa M. Amin
This presentation was presented by Dr Arwa at the Guest Lecturer, UTA45 Jakarta University Webinar.
Low carbohydrate healthy fat (LCHF) Diet as an Effective Therapy for T2DM
Lecture on YouTube:
https://www.youtube.com/watch?v=Fzpg4hT1NkE&t=3s
To download Dr Unwin sugar infographics in different languages:
https://phcuk.org/sugar/
Review paper on Cardiometabolic diseases and their linked metabolic pathways
https://onlinelibrary.wiley.com/doi/full/10.1002/lim2.25
This Presentation is for educational purposes and it has no profit associated with it.
Reference for this Presentation:
Pharmacotherapy: A Pathophysiologic Approach, 11e
Joseph T. DiPiro, Robert L. Talbert, Gary C. Yee, Gary R. Matzke, Barbara G. Wells, L. Michael Posey
This Presentation is for educational purposes and it has no profit associated with it.
Reference for this Presentation:
Pharmacotherapy: A Pathophysiologic Approach, 10e
Joseph T. DiPiro, Robert L. Talbert, Gary C. Yee, Gary R. Matzke, Barbara G. Wells, L. Michael Posey
Premenstrual Syndrome and Premenstrual Dysphoric Disorder Mind-MapsArwa M. Amin
This Mind Map was created By Shahd Al Johny and it was revised and edited By Dr Arwa M Amin. The information of the mind-map are from:
Chapter 96: Menstruation-Related Disorders, Pharmacotherapy: A Pathophysiologic Approach, 11e
This Mind Map was created By Areej Al Mohamadi and it was revised and edited By Dr Arwa M Amin. The information of the mind-map are from:
Chapter 96: Menstruation-Related Disorders, Pharmacotherapy: A Pathophysiologic Approach, 11e
This Presentation is for educational purposes and it has no profit associated with it.
Reference for this Presentation:
Pharmacotherapy: A Pathophysiologic Approach, 10e
Joseph T. DiPiro, Robert L. Talbert, Gary C. Yee, Gary R. Matzke, Barbara G. Wells, L. Michael Posey
Chapter 82: Hormone Therapy in Women
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Acute scrotum is a general term referring to an emergency condition affecting the contents or the wall of the scrotum.
There are a number of conditions that present acutely, predominantly with pain and/or swelling
A careful and detailed history and examination, and in some cases, investigations allow differentiation between these diagnoses. A prompt diagnosis is essential as the patient may require urgent surgical intervention
Testicular torsion refers to twisting of the spermatic cord, causing ischaemia of the testicle.
Testicular torsion results from inadequate fixation of the testis to the tunica vaginalis producing ischemia from reduced arterial inflow and venous outflow obstruction.
The prevalence of testicular torsion in adult patients hospitalized with acute scrotal pain is approximately 25 to 50 percent
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Heavy Menstrual Bleeding Mind Map
1. HMB
Epidemiology
Menstrual blood loss greater than 80 ml per cycle
Or Bleeding greater than 7 day per cycle this
definition has been questioned ?
difficult in quantifying menstrual loss in clinical
practise
there are many women with (heavy menses )
but less than 80ml
Recently, diagnosis is based on the effect of
HMB on quality of life, work productivity &
social activity.
Etiology
PALM -COIN : intermenstrual bleeding as bleeding between predictable and clearly cycle menses
Structural causes (PALM) : Polyp, Adenomyosis .Leiomyoma , Malignancy
Non-structural causes COIN : Coagulopathy . Ovulatory Disorder , Idonendometrial Disorder
AUB: bleeding that is abnormal in regularity , time, volume
Other causes :
1- Pregnancy ( intrauterine pregnancy , ectopic pregnant, ectopic pregnancy , miscarriage )
2- Bleeding disorder ven Willebrand disease , systematic haemophilia , platelet dysfunction ,v111 , IX
factors deficiency
3- Hypothyroidism 4- Uterine structural abnormality (polyp , adenomyosis , leiomyoma, fibrosis )
Clinical presentation
Symptoms :
1. Heavy prolong menstrual flow
2. Fatigue
3. Light headiness
Sign :
1. Orthostatic
2. Tachycardia
3. Pallor if patient have anemia
or acute bloods loss
Laboratory test :
1. CBC , ferritin , hematocrit
,hemoglobin
2. Other tests (prothrombin time
test, activated partial prothrombin
time , INR , von Willebrand factor
antigen , factor VII,IX)
Treatment
Goal :
Menstrual blood flow
Improve patient quality of life
Defer the need for surgical
intervention
General approach treatment :
Patient history
Concomitant concern
ADR effect from some agent
Non pharmacology
therapy :
Surgical treatment
(endometrial ablation
,hysterectomy )
Non-Pharmacological
treatment is reserved
for patients not
responding to
pharmacological
treatment.
Other diagnostic test :
1. pelvic ultrasound
2. Pelvic MRI
3. Endometrial biopsy
4. Hysteroscopy
5. Sonohystogram
6. Papaniacolaou (pap)
smear
Evaluation of therapeutic outcome :
Table number (94-4 )
Identifies significant pharmacological properties of agent
Expected outcome for each agent
Specific monitoring parameters for treatment modalities
in HMB management see table number (94-4 ) ﻣﻬﻢ
ﺟﺪا ﺟﺪا
Pharmacology treatment : First
option treatment before surgery
Estrogen :manage acute
sever bleeding episodes
Women not have any
bleeding disorder
Initial treatment should
continue to prevent
future episodes
Estrogen contain CHCs
+ progesterone
Only as maintenance
therapy
FDA approved drug
estradiol valerate and
dienogest
if CHCs is contraindicated,
use progestin only method.
4-phasic formulation
containing estradiol
1
Four-phasic oral
contraceptive pills
provide 4 different doses
of progestin/estrogen
during a 28-day cycle.
Ethinylestradiol and
levonorgestrel extended
cycle
Dienogest and
estradiol
This mind-map is created by Jana Shaker, Edited and revised By Dr. Arwa M. Amin. The information of the mind-map is
based on Chapter 96: Menstruation-Related Disorders, Pharmacotherapy: A Pathophysiologic Approach, 11e
2. SERUM CREATININE DOSE
(1.4-2.8mg/dl) 1300 mg by mouth twice
daily
(2.9-5.7mg/dl) 1300 mg by mouth once
daily
more than (5.7mg/dl) 650 mg by mouth once daily
NSAID: only during menses
Menorrhagia present
Contraception desired
NO yes
Consider LNG - IUS
Continue
NSAID
Consider tranexamic acid
Or luteal phase
progesterone or x 21 day
starting on day 5
Repeating next cycle Use of LNG-IUS OR
conservative endometrial
ablation surgery
NOyes
Continue
LNG-IUS
Consider
OC
Continue OC Consider conservative
endometrial ablation
surgery
NOyes
yes NO
yes NO
Special population
IUS avoid in
nulliparous
women
Tranexamic acid
Dose adjustment
Caution with history of thrombosis
may cause thromboembolism
Should not be combined with
estrogen containing contraceptive
OC= oral contraceptive
LNG- IUS= levonorgestrel releasing
intrauterine system
Is preferred when pregnancy is desired or
when hormonal therapy is contraindicated
LNG-IUS is
considered the
most effective
treatment to
reduce menstrual
flow
2
This mind-map is created by Jana Shaker, Edited and revised By Dr. Arwa M. Amin. The
information of the mind-map is based on Chapter 96: Menstruation-Related Disorders,
Pharmacotherapy: A Pathophysiologic Approach, 11e
This mind-map is created by Jana Shaker, Edited
and revised By Dr. Arwa M. Amin. The information
of the mind-map is based on Chapter 96:
Menstruation-Related Disorders, Pharmacotherapy:
A Pathophysiologic Approach, 11e
3. 94-4 VERY IMPORTANT from Chapter 96: Menstruation-Related Disorders,
Pharmacotherapy: A Pathophysiologic Approach, 11e